| Product Code: ETC7635666 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The nucleic acid testing (NAT) instrumentation import shipments to Ireland in 2024 continued to see a high level of concentration, with top exporting countries including the USA, UK, Germany, Metropolitan France, and Japan. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market share among these countries. The impressive compound annual growth rate (CAGR) of 24.76% from 2020 to 2024 reflects a thriving market for NAT instrumentation in Ireland. Additionally, the growth rate of 8.09% in 2024 suggests further expansion and opportunities for both importers and manufacturers in the sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Nucleic Acid Testing-NAT Instrumentation Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market - Industry Life Cycle |
3.4 Ireland Nucleic Acid Testing-NAT Instrumentation Market - Porter's Five Forces |
3.5 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Ireland Nucleic Acid Testing-NAT Instrumentation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for accurate and rapid diagnostic testing in Ireland |
4.2.2 Rising prevalence of infectious diseases necessitating advanced testing methods |
4.2.3 Technological advancements leading to the development of more efficient NAT instrumentation |
4.3 Market Restraints |
4.3.1 High initial investment costs associated with acquiring and implementing NAT instrumentation |
4.3.2 Stringent regulatory requirements for approval and use of nucleic acid testing technologies in Ireland |
5 Ireland Nucleic Acid Testing-NAT Instrumentation Market Trends |
6 Ireland Nucleic Acid Testing-NAT Instrumentation Market, By Types |
6.1 Ireland Nucleic Acid Testing-NAT Instrumentation Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.4 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Ligase Chain Reaction (LCR), 2021- 2031F |
6.1.5 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Transcriptionmediated Amplification (TMA), 2021- 2031F |
6.1.6 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Whole Genome Sequencing and Others, 2021- 2031F |
6.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Disease Diagnosis, 2021- 2031F |
6.2.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Forensic Testing, 2021- 2031F |
6.2.4 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.2.5 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Speciality Clinics, 2021- 2031F |
6.3.4 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Diagnostic Centres, 2021- 2031F |
6.3.5 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.3.6 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Nucleic Acid Testing-NAT Instrumentation Market Import-Export Trade Statistics |
7.1 Ireland Nucleic Acid Testing-NAT Instrumentation Market Export to Major Countries |
7.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Imports from Major Countries |
8 Ireland Nucleic Acid Testing-NAT Instrumentation Market Key Performance Indicators |
8.1 Adoption rate of NAT instrumentation in healthcare facilities in Ireland |
8.2 Number of research and development collaborations for enhancing NAT instrumentation capabilities |
8.3 Percentage of healthcare budget allocated towards diagnostic testing technologies in Ireland |
9 Ireland Nucleic Acid Testing-NAT Instrumentation Market - Opportunity Assessment |
9.1 Ireland Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Nucleic Acid Testing-NAT Instrumentation Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Ireland Nucleic Acid Testing-NAT Instrumentation Market - Competitive Landscape |
10.1 Ireland Nucleic Acid Testing-NAT Instrumentation Market Revenue Share, By Companies, 2024 |
10.2 Ireland Nucleic Acid Testing-NAT Instrumentation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here